Natco Pharma Ltd.

Financial

	Natco Pharma	Caplin Point Lab	Jubilant Pharmova
Operational Metrics
API Sector
US DMF Filings	58.0 .	n/a	98.0 .
Pharmaceutical Sector
Number of ANDA's Filed in USA	51.0 .	46.0 .	100.0 .
Number of ANDA's Approved By USFDA	41.0 .	33.0 .	62.0 .
Domestic Sales Growth - YoY	31.2 %	n/a	n/a
R&D as a % of Total Sales	7.6 %	4.4 %	0.33 %
Financials
5 yr Average ROE	13.06 %	20.61 %	8.35 %
5yr average Equity Multiplier	1.18	1.17	2.0
5yr Average Asset Turnover Ratio	0.46	0.72	0.59
5yr Avg Net Profit Margin	23.09 %	24.8 %	7.13 %
Price to Book	1.96	5.5	2.32
P/E	7.5	27.13	22.01
5yr Avg Cash Conversion Cycle	10.54 Days	79.85 Days	-19.21 Days
Inventory Days	99.95 Days	64.55 Days	81.78 Days
Days Receivable	86.16 Days	100.92 Days	51.11 Days
Days Payable	154.15 Days	74.04 Days	173.51 Days
5yr Average Interest Coverage Ratio	46.61	579.71	3.98
5yr Avg ROCE	16.05 %	25.27 %	9.05 %
5yr Avg Operating Profit Margin	30.17 %	30.87 %	18.69 %
5 yr average Debt to Equity	0.06	0.01	0.64
5yr CAGR Net Profit	24.68 %	16.28 %	-38.8 %
5yr Average Return on Assets	11.07 %	17.7 %	4.23 %
Shareholdings
Promoter Holding	49.62 %	70.56 %	50.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.76 %	1.65 %	0.0
Change in Mutual Fund Holding (3 Yrs)	-7.15 %	0.7 %	3.25 %

Business

	Natco Pharma	Caplin Point Lab	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Formulations 59.0 Active Pharmaceutical Ingredient (API) 10.0 Crop Protection 2.0 Branded Generic 0 Generic 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Others 29.0	Product Wise Break-Up Nutritional products 0 0 0 Solid dosage formulations 0 Active pharmaceutical ingredients 0 Radiopharmaceuticals 0 Active Pharmaceutical Ingredient (API) 0 Allergy therapy products 0 Formulations 0 Formulations 75.0 India Branded pharmaceuticals 0 Life science chemicals 0 Branded Generics 25.0 Specialty intermediates 0 Crop Protection 0	Product Wise Break-Up Nutritional products 0 Contract Manufacturing 16.81 Contract Research and Development Services 6.7 Solid dosage formulations 10.82 Active Pharmaceutical Ingredient (API) 9.26 Radiopharmaceuticals 44.9 Active Pharmaceutical Ingredient (API) 0 Anti-allergic 10.21 Formulations 0 Generic 0 India branded pharmaceuticals 0.72 Life science chemicals 0 Branded Generic 0 Specialty intermediates 0 Crop Protection 0 Others 0.58
Segment Break-Up	Segment Break-Up Pharmaceuticals 96.82 Agrochemicals 3.18 CDMO Sterile Injectables 0 Generics 0 Allergy Immunotherapy 0 Radiopharma 0 Proprietary Novel Drugs 0 0 Life Science Ingredients 0	-	Segment Break-Up Allergy Immunotherapy 9.51 Drug discovery and development solutions 16.33 Pharmaceuticals 0 Radiopharma 45.97 Proprietary Novel Drugs 0 Life Science Ingredients 0 Generics 10.91 CDMO Sterile Injectables 17.28 Agrochemicals 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Oncology 58.79 Others 41.21	-	-
Location Wise Break-Up	Location Wise Break-Up USA 70.49 Rest of the World 15.24 India 14.27 Africa 0 LATAM 0 China 0 Americas and Europe 0	Location Wise Break-Up USA 18.0 China 0 Americas and Europe 0 India 0 Rest of the World 0 Africa 2.0 Latin America 80.0	Location Wise Break-Up USA 0 China 0 Americas and Europe 90.17 India 2.33 Rest of the World 7.5 Africa 0 LATAM 0
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceuticals 100.0 Agrochemicals 0 Generics 0 CDMO Sterile Injectables 0 Allergy Immunotherapy 0 Radiopharma 0 Proprietary Novel Drugs 0 Contract Research and Development 0 Life Science Ingredients 0	-	Operating Profit Break-Up Allergy Immunotherapy 20.39 Contract Research and Development 15.39 Pharmaceuticals 0 Radiopharma 41.47 Proprietary Novel Drugs 0 Life Science Ingredients 0 Generics 8.2 CDMO Sterile Injectables 14.56 Agrochemicals 0
Asset Break-Up	Asset Break-Up Pharmaceuticals 92.5 Agrochemicals 7.5 Proprietary Novel Drugs 0 Contract Research and Development 0 Life Science Ingredients 0	-	Asset Break-Up Contract Research and Development 12.96 Pharmaceuticals 0 Proprietary Novel Drugs 2.16 Life Science Ingredients 0 Agrochemicals 0 Others 84.88

Natco Pharma Ltd.

SIGN UP FOR FREE